Venzi, Marcello, David, François, Bellet, Joachim, Cavaccini, Anna, Bombardi, Cristiano, Crunelli, Vincenzo  ORCID: https://orcid.org/0000-0001-7154-9752 and Di Giovanni, Giuseppe
2016.
Role for serotonin2A (5-HT2A) and 2C (5-HT2C) receptors in experimental absence seizures.
Neuropharmacology
108
, pp. 292-304.
10.1016/j.neuropharm.2016.04.016
|
Preview |
PDF
- Published Version
Available under License Creative Commons Attribution. Download (2MB) | Preview |
Abstract
Absence seizures (ASs) are the hallmark of childhood/juvenile absence epilepsy. Monotherapy with first-line anti-absence drugs only controls ASs in 50% of patients, indicating the need for novel therapeutic targets. Since serotonin family-2 receptors (5-HT2Rs) are known to modulate neuronal activity in the cortico-thalamo-cortical loop, the main network involved in AS generation, we investigated the effect of selective 5-HT2AR and 5-HT2CR ligands on ASs in the Genetic Absence Epilepsy Rats from Strasbourg (GAERS), a well established polygenic rat model of these non-convulsive seizures. GAERS rats were implanted with fronto-parietal EEG electrodes under general anesthesia, and their ASs were later recorded under freely moving conditions before and after intraperitoneal administration of various 5-HT2AR and 5-HT2CR ligands. The 5-HT2A agonist TCB-2 dose-dependently decreased the total time spent in ASs, an effect that was blocked by the selective 5-HT2A antagonist MDL11,939. Both MDL11,939 and another selective 5-HT2A antagonist (M100,907) increased the length of individual seizures when injected alone. The 5-HT2C agonists lorcaserin and CP-809,101 dose-dependently suppressed ASs, an effect blocked by the selective 5-HT2C antagonist SB 242984. In summary, 5-HT2ARs and 5-HT2CRs negatively control the expression of experimental ASs, indicating that selective agonists at these 5-HT2R subtypes might be potential novel anti-absence drugs.
| Item Type: | Article |
|---|---|
| Date Type: | Publication |
| Status: | Published |
| Schools: | Schools > Biosciences |
| Uncontrolled Keywords: | Absence epilepsy; Selective serotonin drugs; EEG |
| Publisher: | Elsevier |
| ISSN: | 0028-3908 |
| Funders: | Wellcome Trust |
| Date of First Compliant Deposit: | 26 April 2016 |
| Date of Acceptance: | 12 April 2016 |
| Last Modified: | 19 May 2023 16:50 |
| URI: | https://orca.cardiff.ac.uk/id/eprint/90064 |
Citation Data
Cited 52 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
 |
Edit Item |
Dimensions
Dimensions